Susquehanna Fundamental Investments, LLC G1 Therapeutics, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$5.17 - $16.99 $61,057 - $200,651	-11,810 Reduced 39.49%	18,100 $226,000
Q1 2022 May 16, 2022	SELL	$7.6 - $11.02 $443,992 - $643,788	-58,420 Reduced 66.14%	29,910 $227,000
Q4 2021 Feb 14, 2022	BUY	$10.16 - $16.17 $389,229 - $619,472	38,310 Added 76.59%	88,330 $902,000
Q3 2021 Nov 15, 2021	BUY	$13.16 - $22.47 $658,263 - $1.12 Million	50,020 New	50,020 $671,000
Q2 2021 Aug 11, 2021	SELL	$19.57 - $26.32 $903,742 - $1.22 Million	-46,180 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$17.58 - $32.59 $811,844 - $1.51 Million	46,180 New	46,180 $1.11 Million

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.